|Year : 1976 | Volume
| Issue : 3 | Page : 124-129
Niflumic acid in the management of rheumatoid and osteoarthritis
GH Tilve, JK Lengade, AV Bavadekar, KG Nair
Departments of Medicine and Orthopedics, Seth G. S. Medical College and K.E.M. Hospital, Bombay 400012., India
Nifumic acid in the dosage of 250 mg four times a day and Phenyl butazone 100 nag four times a day were given to 30 classical cases of rheumatoid arthritis and 10 cases of osteoarthritis in a designed double blind cross over trial to find out the efficacy and side effects o f niflumic acid.
It was revealed that niflumic acid is a potent, safe and non-steroidal anti-inflammatory agent, by different indices and parameters used in the study. It was noted to be a better anti-inflammatory agent than phenylbutazone in patient's own assessment, functional status and relief o f pain.
It is practically devoid of side effects and with excellent gastric tolerance.
G H Tilve
Departments of Medicine and Orthopedics, Seth G. S. Medical College and K.E.M. Hospital, Bombay 400012.
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF Not available]*